Caleb Watney and Heidi Williams’ Wednesday, August 24 op-ed commentary, “Drug pricing reforms can hurt innovation,” came as a surprise. The Congressional Budget Office has estimated that the new Climate Change and Drugs Act will result in about 15 fewer new drugs entering the market, compared to an expected 1,300 new drugs, a reduction of about 1%. Lower prices should help millions more people afford to fill the prescriptions they get.